Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00046904 · ClinicalTrials.gov registry record · Phase 3

Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

A Phase 3 study of Unspecified Adult Solid Tumor, Protocol Specific and Cachexia, sponsored by Mayo Clinic.

Completed
Registry status
Phase 3
Development phase
19
Study locations

NCT00046904: Completed Phase 3 study of Unspecified Adult Solid Tumor, Protocol Specific and Cachexia, sponsored by Mayo Clinic.

NCT00046904 is a Phase 3 study of Unspecified Adult Solid Tumor, Protocol Specific and Cachexia that has completed, run by Mayo Clinic. The trial reports 19 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00046904, a Phase 3 study of Unspecified Adult Solid Tumor, Protocol Specific and Cachexia, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 3
Development phase
19
Study locations

Study Summary

RATIONALE: Etanercept is a substance that is being studied as a treatment for cachexia (weight loss) and anorexia (lack of appetite) in patients who have cancer. It is not yet known whether etanercept is effective in improving cancer-related cachexia and anorexia. PURPOSE: Randomized phase III trial to determine the effectiveness of etanercept in treating cancer-related cachexia and anorexia in patients who have advanced cancer.

Conditions Studied

Unspecified Adult Solid Tumor, Protocol Specific Cachexia Anorexia

Interventions

  • BIOLOGICAL etanercept

Study Locations (19)

Iowa

  • CCOP - Cedar Rapids Oncology Project - Cedar Rapids
  • CCOP - Iowa Oncology Research Association - Des Moines
  • Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center - Sioux City

Illinois

  • CCOP - Illinois Oncology Research Association - Peoria
  • CCOP - Carle Cancer Center - Urbana

South Dakota

  • Rapid City Regional Hospital - Rapid City
  • CCOP - Sioux Community Cancer Consortium - Sioux Falls

Alabama

  • MBCCOP - Gulf Coast - Mobile

Arizona

  • Mayo Clinic Scottsdale - Scottsdale

Florida

  • Mayo Clinic - Jacksonville - Jacksonville

Hawaii

  • MBCCOP - Hawaii - Honolulu

Kansas

  • CCOP - Wichita - Wichita

Trial Details

FieldValue
Start Date 2003-05
Phase Phase 3
Mayo Clinic

2,844 total trials

What the finished NCT00046904 record still lists

NCT00046904 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 3 conditions, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 1 intervention - of which etanercept is the first listed.

NCT00046904 lists 19 locations in 15 states (Iowa, Illinois, South Dakota).

Frequently Asked Questions

What is clinical trial NCT00046904 about?

NCT00046904 is a clinical study titled "Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer". RATIONALE: Etanercept is a substance that is being studied as a treatment for cachexia (weight loss) and anorexia (lack of appetite) in patients who have cancer. It is not yet known whether etanercept is effective in improving cancer-related cachexia and anorexia. PURPOSE: Randomized phase III tria...

What is the current status of trial NCT00046904?

This trial is currently completed. It is a Phase 3 study. The study started on 2003-05.

What conditions does trial NCT00046904 study?

This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific, Cachexia, Anorexia.

What interventions are being tested in trial NCT00046904?

The interventions under investigation include: etanercept (BIOLOGICAL).

Who is sponsoring clinical trial NCT00046904?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00046904 being conducted?

This trial has 19 study locations across Alabama, Arizona, Florida, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Unspecified Adult Solid Tumor, Protocol Specific

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00046904, the US trial registry maintained by the National Library of Medicine. NCT00046904 (unsized enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.